Candel Therapeutics Inc. (CADL) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Candel Therapeutics Inc.

    NASDAQ: CADL · Real-Time Price · USD
    5.56
    0.15 (2.77%)
    At close: Oct 03, 2025, 3:59 PM
    5.67
    1.98%
    After-hours: Oct 03, 2025, 06:19 PM EDT

    Candel Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -4.98 -1.12 -18 -6.2
    PEG Ratio
    		 -0.15 -0.00 0.20 -0.91
    PS Ratio
    		 n/a n/a 412.75 1.79K
    PB Ratio
    		 4.15 3.34 -0.52 3.50
    P/FCF Ratio
    		 -10.17 -1.23 -1.58 -9.33
    P/OCF Ratio
    		 -10.17 -1.24 -1.64 -10.1
    OCF/S Ratio
    		 n/a n/a -251.35 -177.74
    Debt / Equity Ratio
    		 0.20 1.79 -0.23 0.01
    Quick Ratio
    		 2.77 2.59 12.81 15.84
    Current Ratio
    		 2.77 2.59 12.81 15.84
    Asset Turnover
    		 n/a n/a 0.00 0.00
    Interest Coverage
    		 -15.97 -74.69 -20.33 -485.4
    Return on Equity
    		 -0.83 -2.98 0.03 -0.56
    Return on Assets
    		 -0.52 -0.92 -0.04 -0.41
    Return on Invested Capital
    		 -0.42 -1.05 -0.07 -0.31
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a -6.9 -0.86
    Net Profit Margin
    		 n/a n/a -22.93 -289.42
    Pretax Profit Margin
    		 n/a n/a -150.35 -288.99
    Operating Profit Margin
    		 n/a n/a -277.78 -205.81
    FCF Margin
    		 n/a n/a -261.73 -192.42
    EBITDA Margin
    		 n/a n/a -138.54 -203.95

    Add to Watchlist